Final OS Analysis Results from Phase III OptiTROP-Lung04 Study of Sacituzumab Tirumotecan (sac-TMT) Presented at 2026 ESMO
Median OS was extended by 8.5 months compared with platinum-based doublet chemotherapy (25.9 vs 17.4 months), with a 31% reduction in the risk of death (HR 0.69; 95% CI 0.54–0.89; one-sided P = 0.0021). The 2-year OS rate was 54.1% vs 37.2%, an...
The Results of Phase III OptiTROP-Lung06 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ESMO Oral Presentation and Simultaneously Published in The New England Journal of Medicine
PFS was significantly prolonged: as assessed by BICR, the risk of disease progression or death was reduced by 51% (HR 0.49; 95% CI 0.36-0.65; P<0.0001 ), and median PFS was 15.0 months (95% CI 9.9-NE) and 5.7 months (95% CI 5.5-7.4) in the two...
Ping An Highlights Green Development Initiatives at International Communication Seminar in Shenzhen Ahead of APEC 2026
HONG KONG and SHANGHAI, Oct. 25, 2026 /PRNewswire/ -- The Seminar on International Communication of Chinese and Foreign Enterprises' Green Development and Global Contributions was held at the Ping An Finance Center in Shenzhen on October 23. Hosted...
Phase II Results of Sacituzumab Tirumotecan (sac-TMT) plus Pembrolizumab in Advanced Urothelial Carcinoma Presented at 2026 ESMO
CHENGDU, China, Oct. 24, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that at the 2026 European Society for Medical Oncology (ESMO) Congress held in Madrid, updated...
TraceLink Launches Track & Trace Lakehouse to Expand Compliance and Analytical Access to End-to-End Serialized Events
Built on the OPUS Lakehouse, the new capability gives life sciences and healthcare customers SQL-based access to serialized event data, with integrated reporting and analytics through OPUS Reports and Dashboards BOSTON, Oct. 23, 2026 /PRNewswire/ --...
GMIF2026 Exhibition Recap: Innovation Across the AI Memory & Storage Chain on Show
SHENZHEN, China, Oct. 23, 2026 /PRNewswire/ -- The 5th GMIF Innovation Summit ( Global Memory Innovation Forum 2026 , GMIF2026), co-hosted by the Shenzhen Memory Industry Association (SMIA) and the School of Integrated Circuits at Peking University,...
The Westin Resort & Spa Ubud, Bali Welcomes 2027 with a Celebration of Culture and Connection
BALI, Indonesia, Oct. 23, 2026 /PRNewswire/ -- As the world prepares to welcome in the New Year, The Westin Resort & Spa Ubud, Bali, invites travellers to celebrate differently through a journey across Indonesia's rich cultural heritage, set...
HoneyNaps Selected for 2026 Eurostars International R&D Project
Korean-Swedish consortium brings together Yonsei University, Dankook University, Uppsala University and Xantage AB Project to develop a non-invasive platform for neurological monitoring Skin-mounted sensors aim to track changes in intracranial...
Wenge AI launches enterprise decision AI seminar series in Shenzhen
SHENZHEN, China, Oct. 23, 2026 /PRNewswire/ -- Wenge AI brought together more than 50 academics, industry experts and business leaders from the Greater Bay Area for the first session of its seminar series on putting decision AI into practice in...
ImmunoForge to Showcase Proprietary Platform Technologies and Next-Generation Oncology & Phase 2 Clinical Pipelines at BIO-Europe 2026
SEOUL, South Korea and COLOGNE, Germany, Oct. 23, 2026 /PRNewswire/ -- ImmunoForge Co., Ltd., a clinical-stage biopharmaceutical company dedicated to developing transformative therapies for rare and intractable diseases, today announced that its...